Ajanta Pharma Dividenden en inkoop
Dividend criteriumcontroles 5/6
Ajanta Pharma is een dividendbetalend bedrijf met een huidig rendement van 1.9% dat ruimschoots wordt gedekt door de winst. Volgende betalingsdatum is op 27th November, 2024 met een ex-dividenddatum van 6th November, 2024.
Belangrijke informatie
1.9%
Dividendrendement
1.0%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 2.9% |
| Toekomstig dividendrendement | 1.0% |
| Dividendgroei | 9.6% |
| Volgende betaaldatum dividend | 27 Nov 24 |
| Ex-dividenddatum | 06 Nov 24 |
| Dividend per aandeel | ₹56.000 |
| Uitbetalingsratio | 78% |
Recente updates van dividend en inkoop
Recent updates
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Oct 31
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Sep 10We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Aug 23Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 04Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E
Aug 01With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case
Jun 01Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price
Apr 05We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Feb 23Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected
Dec 23Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Aug 26These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well
Feb 07Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Oct 24Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Aug 25Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?
Jul 19A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Apr 28Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Mar 14I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut
Feb 06Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Dec 13Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50
Oct 31Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching
Sep 22Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?
Sep 08Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?
Aug 26Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet
Jul 07Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?
Jun 14Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?
May 15Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 10Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Mar 11Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?
Feb 24The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On
Jan 30
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?
Jan 18Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Jan 06Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: De dividendbetalingen van AJANTPHARM zijn de afgelopen 10 jaar volatiel geweest.
Groeiend dividend: De dividendbetalingen van AJANTPHARM zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| Ajanta Pharma Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (AJANTPHARM) | 1.9% |
| Markt onderkant 25% (IN) | 0.3% |
| Markt Top 25% (IN) | 1.2% |
| Gemiddelde industrie (Pharmaceuticals) | 0.7% |
| Analist prognose (AJANTPHARM) (tot 3 jaar) | 1.0% |
Opmerkelijk dividend: Het dividend van AJANTPHARM ( 1.9% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de Indian markt ( 0.25% ).
Hoog dividend: Het dividend van AJANTPHARM ( 1.9% ) behoort tot de top 25% van dividendbetalers in de Indian markt ( 1.17% )
Winstuitkering aan aandeelhouders
Verdiendekking: Bij de huidige payout ratio ( 77.5% ) worden de betalingen van AJANTPHARM gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Op basis van de huidige cash payout ratio ( 76.6% ) worden de dividendbetalingen van AJANTPHARM gedekt door kasstromen.